A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease

NCT02017340 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

511

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Nilvadipine
DRUG: Placebo

Sponsor

Prof Brian Lawlor

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]